125 related articles for article (PubMed ID: 37019375)
1. Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling.
Zhu Z; Cao T; Chen H; Zhang B; Lin C; Cai H
Food Chem Toxicol; 2023 Jun; 176():113757. PubMed ID: 37019375
[TBL] [Abstract][Full Text] [Related]
2. B-GOS alleviates olanzapine-induced lipid disturbances in mice by enriching Akkermansia and upregulation of PGRMC1-Wnt signaling.
Zeng C; Chen H; Cao T; Wang L; Jiao S; Lin C; Zhang B; Cai H
Food Chem Toxicol; 2024 Mar; 185():114490. PubMed ID: 38325638
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane.
Isaacson RH; Beier JI; Khoo NK; Freeman BA; Freyberg Z; Arteel GE
J Nutr Biochem; 2020 Jul; 81():108399. PubMed ID: 32388251
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway.
Li R; Zhu W; Huang P; Yang Y; Luo F; Dai W; Shen L; Pei W; Huang X
Biomed Pharmacother; 2021 Sep; 141():111803. PubMed ID: 34146854
[TBL] [Abstract][Full Text] [Related]
5. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
6. Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis.
Lee SR; Kwon SW; Kaya P; Lee YH; Lee JG; Kim G; Lee GS; Baek IJ; Hong EJ
Sci Rep; 2018 Oct; 8(1):15711. PubMed ID: 30356113
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs.
Schmidt RH; Jokinen JD; Massey VL; Falkner KC; Shi X; Yin X; Zhang X; Beier JI; Arteel GE
J Pharmacol Exp Ther; 2013 Oct; 347(1):126-35. PubMed ID: 23926289
[TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Fish Oil and Olanzapine Effects on Gut Microbiota in Diet-Induced Obese Mice.
Abbas MM; Soto P; Ramalingam L; El-Manzalawy Y; Bensmail H; Moustaid-Moussa N
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057526
[TBL] [Abstract][Full Text] [Related]
9. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
[TBL] [Abstract][Full Text] [Related]
10. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
11. Agaricus bisporus supplementation reduces high-fat diet-induced body weight gain and fatty liver development.
Iñiguez M; Pérez-Matute P; Villanueva-Millán MJ; Recio-Fernández E; Roncero-Ramos I; Pérez-Clavijo M; Oteo JA
J Physiol Biochem; 2018 Nov; 74(4):635-646. PubMed ID: 30288689
[TBL] [Abstract][Full Text] [Related]
12. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
[TBL] [Abstract][Full Text] [Related]
14. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
[TBL] [Abstract][Full Text] [Related]
15. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
17. Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress.
Wei K; Wei Y; Xu W; Lu F; Ma H
Food Funct; 2022 May; 13(10):5782-5793. PubMed ID: 35537139
[TBL] [Abstract][Full Text] [Related]
18. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
19. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
Kim S; Hong J; Jeon R; Kim HS
Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling.
Kim MH; Seong JB; Huh JW; Bae YC; Lee HS; Lee DS
Redox Biol; 2020 Jan; 28():101315. PubMed ID: 31505325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
